Question 1

What is the catalog number for 10,11-Dimethoxy-6,8,13,13a-tetrahydro-5H-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinoline?

Accepted Answer

The catalog number for 10,11-Dimethoxy-6,8,13,13a-tetrahydro-5H-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinoline is OR1065302.

Question 2

Is 10,11-Dimethoxy-6,8,13,13a-tetrahydro-5H-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinoline in stock?

Accepted Answer

10,11-Dimethoxy-6,8,13,13a-tetrahydro-5H-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinoline is currently made to order / not held in immediate stock. Contact us for lead time.

Question 3

Can this product be used for co-immunoprecipitation (Co-IP)?

Accepted Answer

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

Question 4

Is this kit compatible with automated liquid handling platforms?

Accepted Answer

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

Question 5

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

10,11-Dimethoxy-6,8,13,13a-tetrahydro-5H-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinoline

Product Specifications

CAS Number

Purity

Smiles

Available Sizes

Frequently Asked Questions

Explore Other Products

TNF alpha (TNF706 + P/T2), 1mg/mL

Anti-SP140 Antibody Picoband®

Tyrosinase-Related Protein-1 (TYRP-1) (Melanoma Marker), CF568 conjugate, 0.1mg/mL

Neurofilament (NF-H) (Neuronal Marker) (rNF421), CF488A conjugate, 0.1mg/mL

CD45RA (PTPRC/1148), CF740 conjugate, 0.1mg/mL

Anti-DR5/TNFRSF10B Antibody Picoband® (Dylight488 Conjugate)